Healthcare - Sector
ARWR is currently covered by 13 analysts with an average price target of $97.92. This is a potential upside of $56.55 (136.69%) from yesterday's end of day stock price of $41.37.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 310 price targets and 296 ratings on display. The stock rating distribution of ARWR is 77.78% BUY and 22.22% HOLD.
Analysts' price targets on this stock were met 77.44% of the time, taking 390.86 days on average.
Highest price target for ARWR is $126, Lowest price target is $46, average price target is $97.92.
Most recent stock forecast was given by ERIC JOSEPH from CITI. First documented stock forecast 07-Feb-2014.
Currently out of the existing stock ratings of ARWR, 10 are a HOLD (22.22%), 35 are a BUY (77.78%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2026
$105
$63.63 (153.81%)
$108
5 days ago
(17-Nov-2026)
Buy Since 14-Jul-2026
$96
$54.63 (132.05%)
$98
9 days ago
(13-Nov-2026)
0/2 (0%)
$48.22 (100.92%)
Buy Since 12-May-2020
$100
$58.63 (141.72%)
$100
9 days ago
(13-Nov-2026)
21/23 (91.3%)
$52.22 (109.29%)
565
Buy Since 16-Sep-2020
$115
$73.63 (177.98%)
$115
1 months 7 days ago
(15-Oct-2026)
25/31 (80.65%)
$56.5 (96.58%)
544
Buy Since 17-Sep-2020
$120
$78.63 (190.07%)
$120
1 months 7 days ago
(15-Oct-2026)
14/37 (37.84%)
$61.5 (105.13%)
403
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ARWR (Arrowhead Pharmaceuticals)?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?